Team:Paris Bettencourt/Notebook/Trojan Horse/Friday 28th June.html

From 2013.igem.org

(Difference between revisions)
(Created page with "<html> <div class ="tbnote"> <h2>Trojan Horse</h2> <a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Trojan_Horse" target="_blank" class="tbnotelogo THlogo"> ASDF </a>...")
 
(One intermediate revision not shown)
Line 7: Line 7:
<p><b><em>
<p><b><em>
<!-- === Modify from here === -->
<!-- === Modify from here === -->
-
Place your twit here
+
 
<!-- === To here          === -->
<!-- === To here          === -->
</br></em></b></p>
</br></em></b></p>
<!-- === Modify from here === -->
<!-- === Modify from here === -->
-
Place your note here
+
 
<p lang="en-US">
<p lang="en-US">
     sRNA design
     sRNA design

Latest revision as of 19:58, 3 October 2013

Trojan Horse

28th July


sRNA design

A description...

red sequences:

pACYCDuet-1 (CmR) : ATATCCAGTGATTTTTTTCTCCAT

pCOLADuet-1 (KanR) : CGTTTCCCGTTGAATATGGCTCAT

We decided that targeting only two different antibiotic resistance will be enough for a proof of concept. We give up AmpR because otherwise they might be experimental issues with AmpR that is also on phagemid litmus28i.